Announcement.

BIOMED-LUBLIN WYTWÓRNIA SUROWIC I SZCZEPIONEK SA (23/2018) Notification of the transaction referred to in art. 19 para. 1 of MAR Regulation

Legal basis: Article 19 para. 3 MAR - information on transactions performed by persons discharging managerial responsibilities.
The Management Board of "BIOMED-LUBLIN" Wytwórnia Surowic i Szczepionek SA ("Company", "Issuer") informs that on August 13, 2018, it received notification pursuant to art. 19 para. 1 of the MAR Regulation on the transaction of purchase of the Company's shares, performed by Medicare - Galenica Sp. z o.o., which is closely related to the managing person of the Issuer - Mr Dariusz Kucowicz, who is a member of the Issuer's Supervisory Board.
The content of the notification is attached to this report.
Legal basis:
Article 19 para. 3 MAR - information on transactions performed by persons discharging managerial responsibilities

Source: company website, investor relations, current and periodic reports.

ALL COMPANY ANNOUNCMENTS
Company information
Company name:Biomed-Lublin Wytwórnia Surowic i Szczepionek SA
ISIN:PLBMDLB00018
NIP:7122591951
Adress: ul. Uniwersytecka 10 20-029 Lublin
Phone:+48 81 5330926
website:www.biomed.lublin.pl

Copyright © 2017 PolandStockExchange
This website uses cookies (Regulations / Cookie Policy).